WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2007018469) OXOPYRIDYL QUINOLINE AMIDES AS NK3 RECEPTOR MODULATORS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2007/018469    International Application No.:    PCT/SE2006/000941
Publication Date: 15.02.2007 International Filing Date: 10.08.2006
IPC:
C07D 401/12 (2006.01), A61K 31/4709 (2006.01), A61P 11/00 (2006.01), A61P 25/00 (2006.01), A61P 25/18 (2006.01), A61P 25/22 (2006.01), A61P 25/24 (2006.01), A61P 25/28 (2006.01), A61P 29/00 (2006.01), A61P 35/00 (2006.01)
Applicants: ASTRAZENECA AB [SE/SE]; S-151 85 Södertälje (SE) (For All Designated States Except US).
ALBERT, Jeffrey, S. [US/US]; (US) (For US Only).
ALHAMBRA, Cristobal [ES/US]; (US) (For US Only).
KANG, James [US/US]; (US) (For US Only).
KOETHER, Gerard, M. [US/US]; (US) (For US Only).
SIMPSON, Thomas, R. [US/US]; (US) (For US Only).
WOODS, James [US/US]; (US) (For US Only).
LI, Yan [US/US]; (US) (For US Only)
Inventors: ALBERT, Jeffrey, S.; (US).
ALHAMBRA, Cristobal; (US).
KANG, James; (US).
KOETHER, Gerard, M.; (US).
SIMPSON, Thomas, R.; (US).
WOODS, James; (US).
LI, Yan; (US)
Agent: ASTRAZENECA; Global Intellectual Property, S-151 85 Södertälje (SE)
Priority Data:
60/707,379 11.08.2005 US
Title (EN) OXOPYRIDYL QUINOLINE AMIDES AS NK3 RECEPTOR MODULATORS
(FR) MODULATEURS RÉCÉPTEURS NK3 EN TANT QU’AMIDES DE QUINOLÉINE OXOPYRIDYL
Abstract: front page image
(EN)Compounds of Formula I wherein R1, A, R2, R3, R4, R5, n, m and q are as described in the specification, pharmaceutically-acceptable salts, methods of making, pharmaceutical compositions containing and methods for using the same.
(FR)La présente invention concerne des composés de la Formule I, dans laquelle R1, A, R2, R3, R4, R5, n, m et q sont ainsi que décrit dans la spécification, des sels acceptables sur le plan pharmaceutique, des procédés de fabrication, des compositions pharmaceutiques les contenant et des procédés pour les utiliser.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)